LifeVantage (NASDAQ:LFVN) Stock Crosses Below 200-Day Moving Average of $6.42

LifeVantage Co. (NASDAQ:LFVN - Get Free Report)'s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.42 and traded as low as $6.03. LifeVantage shares last traded at $6.05, with a volume of 42,786 shares traded.

LifeVantage Stock Performance

The business has a fifty day moving average price of $6.60 and a 200 day moving average price of $6.42. The company has a market cap of $82.43 million, a price-to-earnings ratio of 27.85 and a beta of 0.78.

LifeVantage (NASDAQ:LFVN - Get Free Report) last issued its earnings results on Tuesday, January 30th. The company reported $0.10 earnings per share (EPS) for the quarter. LifeVantage had a return on equity of 19.96% and a net margin of 1.40%. The business had revenue of $51.62 million during the quarter.

LifeVantage Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a $0.035 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $0.14 dividend on an annualized basis and a yield of 2.19%. LifeVantage's payout ratio is presently 60.87%.

Institutional Investors Weigh In On LifeVantage

An institutional investor recently bought a new position in LifeVantage stock. Ritholtz Wealth Management purchased a new stake in LifeVantage Co. (NASDAQ:LFVN - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 20,271 shares of the company's stock, valued at approximately $131,000. Ritholtz Wealth Management owned about 0.16% of LifeVantage at the end of the most recent quarter. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.